Literature DB >> 19717270

Measurement of self-reported HIV risk behaviors in injection drug users: comparison of standard versus timeline follow-back administration procedures.

Marc L Copersino1, Christina S Meade, George E Bigelow, Robert K Brooner.   

Abstract

This study compares the frequencies of retrospective self-reported HIV high-risk drug use and sexual behaviors in 127 out-of-treatment injection drug users using the HIV Risk Questionnaire (HRQ) across two administration methods: (a) a brief standard quantity-frequency approach covering the past 30 days and (b) a lengthier timeline follow-back (TLFB) procedure for improving recall. The two procedures produced similar frequencies of risk behavior across most items (80%) and good intra- and interclass correlation coefficients. The TLFB, however, resulted in higher frequencies for two risk behavior questions-sharing of any drug injection equipment and having any type of unprotected sex. The TLFB is a well-established procedure for retrospective assessment of HIV risk behavior and a good choice when precision in measuring these behaviors is a primary focus of the work. In contrast, the brief HRQ-Standard interview procedure appears to be a reasonable choice for clinical, research, and health-related surveys where the primary focus is broader than HIV risk behavior.

Entities:  

Mesh:

Year:  2009        PMID: 19717270      PMCID: PMC2789860          DOI: 10.1016/j.jsat.2009.06.004

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  13 in total

1.  The validity of self-reported cocaine use in two groups of cocaine abusers.

Authors:  D Hersh; C L Mulgrew; J Van Kirk; H R Kranzler
Journal:  J Consult Clin Psychol       Date:  1999-02

2.  Assessing sexual risk behaviour with the Timeline Followback (TLFB) approach: continued development and psychometric evaluation with psychiatric outpatients.

Authors:  M P Carey; K B Carey; S A Maisto; C M Gordon; L S Weinhardt
Journal:  Int J STD AIDS       Date:  2001-06       Impact factor: 1.359

3.  Comparison of a quick drinking screen with the timeline followback for individuals with alcohol problems.

Authors:  Linda Carter Sobell; Sangeeta Agrawal; Mark B Sobell; Gloria I Leo; Lisa Johnson Young; John A Cunningham; Edward R Simco
Journal:  J Stud Alcohol       Date:  2003-11

4.  Reliability and validity of the aggregate method of determining number of cigarettes smoked per day.

Authors:  P W Gariti; A I Alterman; R N Ehrman; H M Pettinati
Journal:  Am J Addict       Date:  1998

5.  Antisocial personality disorder and HIV infection among intravenous drug abusers.

Authors:  R K Brooner; L Greenfield; C W Schmidt; G E Bigelow
Journal:  Am J Psychiatry       Date:  1993-01       Impact factor: 18.112

6.  Validity of intravenous drug abusers' self-reported changes in HIV high-risk drug use behaviors.

Authors:  L Greenfield; G E Bigelow; R K Brooner
Journal:  Drug Alcohol Depend       Date:  1995-08       Impact factor: 4.492

7.  The Fifth Edition of the Addiction Severity Index.

Authors:  A T McLellan; H Kushner; D Metzger; R Peters; I Smith; G Grissom; H Pettinati; M Argeriou
Journal:  J Subst Abuse Treat       Date:  1992

8.  Self-reports of alcohol use, drug use and sexual behavior: expanding the Timeline Follow-back technique.

Authors:  L T Midanik; A M Hines; D C Barrett; J P Paul; G M Crosby; R D Stall
Journal:  J Stud Alcohol       Date:  1998-11

9.  Condom use rates for specific sexual behaviors among opioid abusers entering treatment.

Authors:  V L King; R K Brooner; G E Bigelow; C W Schmidt; L J Felch; P M Gazaway
Journal:  Drug Alcohol Depend       Date:  1994-06       Impact factor: 4.492

10.  Reliability of the timeline follow-back sexual behavior interview.

Authors:  L S Weinhardt; M P Carey; S A Maisto; K B Carey; M M Cohen; S M Wickramasinghe
Journal:  Ann Behav Med       Date:  1998
View more
  11 in total

1.  Buprenorphine-naloxone treatment responses differ between young adults with heroin and prescription opioid use disorders.

Authors:  Mauricio Romero-Gonzalez; Abtin Shahanaghi; Gregory J DiGirolamo; Gerardo Gonzalez
Journal:  Am J Addict       Date:  2017-11-16

2.  Assessing criminal justice involvement as an indicator of human immunodeficiency virus risk among women in methadone treatment.

Authors:  Matthew W Epperson; Maria R Khan; Daniel P Miller; Brian E Perron; Nabila El-Bassel; Louisa Gilbert
Journal:  J Subst Abuse Treat       Date:  2010-03-31

3.  Differences between men and women in condom use, attitudes, and skills in substance abuse treatment seekers.

Authors:  Donald A Calsyn; Michelle Peavy; Elizabeth A Wells; Aimee N C Campbell; Mary A Hatch-Maillette; Shelly F Greenfield; Susan Tross
Journal:  Am J Addict       Date:  2013 Mar-Apr

4.  A Brief Assessment for HIV Risk: The TCU HVHP Form.

Authors:  Grace A Rowan; George W Joe; Wayne E K Lehman; Kevin Knight
Journal:  J Correct Health Care       Date:  2016-07

5.  Concurrent validity of an online version of the Timeline Followback assessment.

Authors:  Eric R Pedersen; Joel Grow; Sean Duncan; Clayton Neighbors; Mary E Larimer
Journal:  Psychol Addict Behav       Date:  2012-04-09

6.  Extended-Release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living With HIV With Opioid Use Disorders Transitioning to the Community: Results of a Double-Blind, Placebo-Controlled Randomized Trial.

Authors:  Sandra A Springer; Angela Di Paola; Marwan M Azar; Russell Barbour; Breanne E Biondi; Maureen Desabrais; Thomas Lincoln; Daniel J Skiest; Frederick L Altice
Journal:  J Acquir Immune Defic Syndr       Date:  2018-05-01       Impact factor: 3.731

7.  Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for HIV-infected, opioid dependent prisoners and jail detainees who are transitioning to the community.

Authors:  Angela Di Paola; Thomas Lincoln; Daniel J Skiest; Maureen Desabrais; Frederick L Altice; Sandra A Springer
Journal:  Contemp Clin Trials       Date:  2014-09-18       Impact factor: 2.226

8.  Memantine improves buprenorphine/naloxone treatment for opioid dependent young adults.

Authors:  Gerardo Gonzalez; Gregory DiGirolamo; Mauricio Romero-Gonzalez; David Smelson; Douglas Ziedonis; Monika Kolodziej
Journal:  Drug Alcohol Depend       Date:  2015-09-30       Impact factor: 4.492

9.  Incongruence in doping related attitudes, beliefs and opinions in the context of discordant behavioural data: in which measure do we trust?

Authors:  Andrea Petróczi; Martina Uvacsek; Tamás Nepusz; Nawed Deshmukh; Iltaf Shah; Eugene V Aidman; James Barker; Miklós Tóth; Declan P Naughton
Journal:  PLoS One       Date:  2011-04-26       Impact factor: 3.240

10.  Evaluation of a pilot medication-assisted therapy program in Kazakhstan: successes, challenges, and opportunities for scaleup.

Authors:  Azizbek A Boltaev; Anna P Deryabina; Almas Kusainov; Andrea A Howard
Journal:  Adv Prev Med       Date:  2012-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.